COVID-19

specific

An acute infection of the respiratory tract that is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Based on currently available information, SARS-CoV-2 is thought to mainly spread from person to person through respiratory droplets. Typically, there is a two- to 14-day incubation period and infected persons can present with no symptoms or mild to severe fever, dry cough, fatigue, and difficulty breathing. Dysgeusia, anosmia, and gastrointestinal and flu-like symptoms

41

Centers

0

Active Trials

$196M

Cancer Funding

Top Centers for COVID-19(41)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
68.3
2
NCI Comprehensive
Active Research Program
67.4
3
NCI Comprehensive
Active Research Program
66.6
4
NCI Comprehensive
Active Research Program
65.7
5
NCI Comprehensive
Active Research Program
64.9
6
NCI Comprehensive
Active Research Program
64.0
763.2
8
NCI Comprehensive
Active Research Program
62.3
9
NCI Comprehensive
Active Research Program
61.5
10
NCI Comprehensive
Active Research Program
60.6
11
Active Research Program
59.8
12
NCI Comprehensive
Active Research Program
58.9
13
NCI Comprehensive
Active Research Program
58.0
14
NCI Comprehensive
Active Research Program
57.2
15
NCI Comprehensive
Active Research Program
56.3
16
NCI Clinical
Active Research Program
55.5
17
NCI Comprehensive
Active Research Program
54.6
18
NCI Comprehensive
Active Research Program
53.8
1952.9
20
NCI Clinical
Active Research Program
52.1
21
NCI Comprehensive
Active Research Program
51.2
22
NCI Comprehensive
Active Research Program
50.4
23
NCI Comprehensive
Active Research Program
49.5
24
NCI Comprehensive
Active Research Program
48.7
25
NCI Comprehensive
Active Research Program
47.8
26
NCI Comprehensive
Active Research Program
47.0
27
NCI Comprehensive
Active Research Program
46.1
28
GW Cancer CenterWashington, DC
Active Research Program
45.2
29
NCI Comprehensive
Active Research Program
44.4
30
Active Research Program
43.5
31
NCI Comprehensive
Active Research Program
42.7
32
Active Research Program
41.8
33
NCI Comprehensive
Active Research Program
41.0
34
NCI Comprehensive
Active Research Program
40.1
35
Active Research Program
39.3
36
Stephenson Cancer CenterOklahoma City, OK
NCI Clinical
Active Research Program
38.4
37
NCI Comprehensive
Active Research Program
37.6
38
NCI Comprehensive
Active Research Program
36.7
39
Active Research Program
35.9
4034.6
4134.6

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →